ERBB2 and triple-negative breast carcinoma: Bioinformatics-based gene expression profiling may reveal distinct gene expression patterns that are associated with different subtypes of breast cancer such as in hormone receptor-positive breast cancer, HER2-positive breast cancer, and Triple-negative breast cancer.